Amine N-Oxygenation by FMO3 and FMO4
Amine N-Oxygenation by FMO3 and FMO4
批准号:
6874304
负责人:
John R Cashman
金额:
$37.44万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-15 至 2009-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Variation in neurotransmitter
transporters, receptors and abnormal levels of neurotransmitters potentially
are involved in neurological diseases including schizophrenia, bipolar
affective disorder, autism, affective disorder, late onset Alzheimer's disease,
Parkinson's disease and others. Fundamental information characterizing human
neurotransmitter metabolism associated with neurodegenerative diseases could
provide new approaches to understanding the pathology and developing new
therapeutics. Our central hypothesis is that lack of detoxication of endogenous
or xenobiotic amines underlies the pathological condition of some CNS diseases.
The human flavin-containing monooxygenase (FMO) is one of the major human
enzyme systems that contribute to the detoxication of endogenous, environmental
and dietary nitrogen-containing substances. The overall goal of our work is to
understand the details of FMO-mediated N-oxygenation of amines and
hydroxylamines. Accumulation of hydroxylamines in the CNS may lead to
cytotoxicity or apoptosis. To test this, fundamental information about human
brain FMO N-oxygenation is required. The overall goal will be accomplished by
addressing five Specific Aims including: Aim 1: cDNA-express the major forms of
human brain FMO; Aim 2: Chemically synthesize amine metabolites of human brain
FMO; Aim 3: Determine the kinetics and mechanism of human brain FMO amine
N-oxygenation; Aim 4: Test the effects of human brain FMO amine metabolites on
neuronal cell function including cytotoxicity and apoptosis, and Aim 5:
Investigate the mechanism of amine metabolites on human neurotransmitter
function. The significance is that fundamental biochemical information will
result in new insight about the way endogenous and xenobiotic and dietary
amines are metabolized in human brain. Such fundamental information will be
useful in the development of safer drugs, the prevention of adverse drug
reactions and the protection of humans from disease.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.
人含黄素单加氧酶 3 的遗传变异对 N-和 S-氧化活性的影响。
DOI:
--
发表时间:
2007
期刊:
Drug Metab Dispos. 35(3)
影响因子:
--
作者:
[Shimizu, M. et al., Shimizu M. et al., Yamazaki H. et al., Shimizu M. et al.]
通讯作者:
Shimizu M. et al.
DOI:
10.1016/j.ymgme.2009.02.006
发表时间:
2009-06
期刊:
MOLECULAR GENETICS AND METABOLISM
影响因子:
3.8
作者:
[Motika, Meike S., Zhang, Jun, Zheng, Xueying, Riedler, Kiersten, Cashman, John R.]
通讯作者:
Cashman, John R.
The role of flavin-containing monooxygenases in drug metabolism and development.
含黄素单加氧酶在药物代谢和开发中的作用。
DOI:
--
发表时间:
2003
期刊:
Current opinion in drug discovery & development.
影响因子:
--
作者:
[Cashman,JohnR]
通讯作者:
Cashman,JohnR
Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.
不同小鼠炎症模型中肝脏含黄素单加氧酶基因的调控。
DOI:
10.1124/dmd.108.025338
发表时间:
2009
期刊:
Drug metabolism and disposition: the biological fate of chemicals
影响因子:
--
作者:
[Zhang,Jun, Chaluvadi,MadhusudanaR, Reddy,Rob, Motika,MeikeS, Richardson,TerrilynA, Cashman,JohnR, Morgan,EdwardT]
通讯作者:
Morgan,EdwardT
DOI:
10.1016/j.ymgme.2006.08.008
发表时间:
2007-01-01
期刊:
MOLECULAR GENETICS AND METABOLISM
影响因子:
3.8
作者:
[Yamazaki, Hiroshi, Fujita, Haruka, Shimizu, Makiko]
通讯作者:
Shimizu, Makiko
共 11 条
Novel Small Molecule Therapeutics for Pancreatic Cancer
-
批准号:8647088
-
项目类别:
-
资助金额:$24.06万
-
财政年份:2014
-
负责人:John R Cashman
-
依托单位:
Small Molecule Toolbox: Cardiomyocytes from Human Stem Cells
-
批准号:8125859
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2011
-
负责人:John R Cashman
-
依托单位:
Novel Medicinal Chemicals: Cardiomyogenesis from Human Stem Cells
-
批准号:8058646
-
项目类别:
-
资助金额:$17.25万
-
财政年份:2011
-
负责人:John R Cashman
-
依托单位:
Biosensor for real-time chemical monitoring
-
批准号:7224735
-
项目类别:
-
资助金额:$58.58万
-
财政年份:2006
-
负责人:John R Cashman
-
依托单位:
Biosensor for real-time chemical monitoring
-
批准号:7470608
-
项目类别:
-
资助金额:$84.48万
-
财政年份:2006
-
负责人:John R Cashman
-
依托单位:
Biosensor for real-time chemical monitoring
-
批准号:7644836
-
项目类别:
-
资助金额:$84.92万
-
财政年份:2006
-
负责人:John R Cashman
-
依托单位:
Biosensor for real-time chemical monitoring
-
批准号:7294268
-
项目类别:
-
资助金额:$87.1万
-
财政年份:2006
-
负责人:John R Cashman
-
依托单位:
Biosensor for real-time chemical monitoring
-
批准号:7903299
-
项目类别:
-
资助金额:$85.72万
-
财政年份:2006
-
负责人:John R Cashman
-
依托单位:
New Opioids for Alcoholism
-
批准号:7052209
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2006
-
负责人:John R Cashman
-
依托单位:
AMINE N-OXYGENATION BY FM03 AND FM04
-
批准号:6971635
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2004
-
负责人:John R Cashman
-
依托单位:
Amine N-Oxygenation by FMO3 and FMO4
-
批准号:6437030
-
项目类别:
-
资助金额:$42.42万
-
财政年份:2002
-
负责人:John R Cashman
-
依托单位:
Amine N-Oxygenation by FMO3 and FMO4
-
批准号:6621848
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2002
-
负责人:John R Cashman
-
依托单位:
Amine N-Oxygenation by FMO3 and FMO4
-
批准号:6722773
-
项目类别:
-
资助金额:$37.44万
-
财政年份:2002
-
负责人:John R Cashman
-
依托单位:
COMBINATORIAL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE
-
批准号:2467370
-
项目类别:
-
资助金额:$0.12万
-
财政年份:1997
-
负责人:John R Cashman
-
依托单位:
NOVEL COCAINE ESTERASES
-
批准号:2700801
-
项目类别:
-
资助金额:$1.85万
-
财政年份:1997
-
负责人:John R Cashman
-
依托单位:
COMBINATORIAL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE
-
批准号:6355925
-
项目类别:
-
资助金额:$1.66万
-
财政年份:1997
-
负责人:John R Cashman
-
依托单位:
COMBINATORIAL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE
-
批准号:6082188
-
项目类别:
-
资助金额:$1.03万
-
财政年份:1997
-
负责人:John R Cashman
-
依托单位:
COMBINATORIAL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE
-
批准号:2879341
-
项目类别:
-
资助金额:$4.51万
-
财政年份:1997
-
负责人:John R Cashman
-
依托单位:
NOVEL COCAINE ESTERASES
-
批准号:2012766
-
项目类别:
-
资助金额:$7.61万
-
财政年份:1997
-
负责人:John R Cashman
-
依托单位:
COMBINATORIAL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE
-
批准号:6174721
-
项目类别:
-
资助金额:$29.88万
-
财政年份:1997
-
负责人:John R Cashman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: